Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (3444)	6/23/1998 10:28:00 PM
From: Peter V	Respond to of 5736

Janybird, you don't get it, do you? I never said he wasn't qualified as a pediatrician or neonatologist, I'm sure that he is. Maisels admits that he doesn't know how markets are calculated, yet CCSI has him opine on that issue. How is it credible? How is it relative to his training and experience? It's not. He is a doctor, not a medical products market evaluator. Maisels himself admitted he is not qualified to opine on how markets are calculated, yet all you can do is show me is medical qulifications, which I never questioned. When the good doctor says he is not qualified to calculate markets, how can you tell me he is? Do you know something Maisels does not? The point here is, that CCSI will live or die by market penetration. If they don't get any, then the BiliTest will never generate revenues. Doesn't matter if the device works, doesn't matter if it does everything Maisels says it will do. If they don't get the market penetration, your CCSI investment is toast. All the credentials in the world won't change that.